Elixinol Wellness Ltd (ASX: EXL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Elixinol Wellness Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.02 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.27 billion
Earnings per share -0.016
Dividend per share N/A
Year To Date Return -46.43%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Elixinol Wellness Ltd (ASX: EXL)
    Latest News

    a woman
    Share Fallers

    Why these ASX cannabis shares just crashed to all-time lows

    AusCann Group Holdings Ltd (ASX:AC8) and these ASX cannabis shares have just crashed to all-time lows...

    Read more »

    a woman
    Share Fallers

    Elixinol share price slumps 6% after sale of Japanese cannabis arm

    The Elixinol Global Ltd (ASX: EXL) share price has slumped in early trade after the ASX cannabis stock sold its…

    Read more »

    a woman
    ⏸️ Best ASX Shares

    The only ASX cannabis share I'd consider buying

    Why Ecofibre Ltd (ASX: EOF) is my ASX Cannabis pick.

    Read more »

    a woman
    Share Fallers

    Cannabis company Elixinol Global sinks lower on Q3 update

    The Elixinol Global Ltd (ASX:EXL) share price has sunk lower following its Q3 update. Here's why the cannabis company is…

    Read more »

    a woman
    Share Fallers

    Why Botanix, Elixinol Global, Pro Medicus, & Tinybeans shares tumbled lower

    The Botanix Pharmaceuticals Ltd (ASX:BOT) share price and the Pro Medicus Limited (ASX:PME) share price are two of four tumbling…

    Read more »

    a woman
    Share Fallers

    Why cannabis company Elixinol Global crashed 10% lower today

    The Elixinol Global Ltd (ASX:EXL) share price has crashed lower following a breach by its Japan business...

    Read more »

    a woman
    ⏸️ Shares to Watch

    What is the best ASX cannabis share to buy for 2020?

    ASX cannabis shares have had a bumpy few months. Here's why Ecofibre Limited (ASX: EOF) could be one of the…

    Read more »

    a woman
    Share Fallers

    What's next for these 4 beaten-down ASX cannabis stocks?

    Why are these ASX-listed cannabis shares falling in price at the same time Australian lawmakers are flirting with legalisation?

    Read more »

    a woman
    Share Gainers

    Why this beaten-down ASX cannabis stock is turning around

    Elixinol Global Limited (ASX: EXL) has fallen hard this year. However, today, the stock is up 2.71%. Is this the…

    Read more »

    a woman
    Growth Shares

    3 beaten down ASX shares to watch in September

    With growth companies operating on high-flying price-to-earnings multiples, its stock price is highly sensitive to any company-specific or market wide…

    Read more »

    a woman
    Share Fallers

    2 falling ASX cannabis stocks to watch closely

    We take a closer look at Elixinol Global Ltd (ASX: EXL) and Althea Group Holdings Ltd (ASX: AGH), two of…

    Read more »

    a woman
    Share Gainers

    This ASX cannabis share just surged 16% higher after announcing a deal with Costco

    The Cann Global Ltd (ASX:CGB) share price has surged 16% higher after announcing a deal with Costco...

    Read more »

    EXL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Elixinol Wellness Ltd

    Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.

    EXL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Mar 2024 $0.01 $0.00 0.00% 15,682,043 $0.01 $0.01 $0.01
    26 Mar 2024 $0.01 $0.00 0.00% 410,861 $0.01 $0.01 $0.01
    25 Mar 2024 $0.01 $0.00 0.00% 23,181,745 $0.01 $0.01 $0.01
    22 Mar 2024 $0.01 $0.00 0.00% 7,761,660 $0.01 $0.01 $0.01
    21 Mar 2024 $0.01 $0.00 0.00% 527,009 $0.01 $0.01 $0.01
    20 Mar 2024 $0.01 $0.00 0.00% 1,697,652 $0.01 $0.01 $0.01
    19 Mar 2024 $0.01 $0.00 0.00% 183,352 $0.01 $0.01 $0.01
    18 Mar 2024 $0.01 $0.00 0.00% 39,497 $0.01 $0.01 $0.01
    15 Mar 2024 $0.01 $0.00 0.00% 73,328 $0.01 $0.01 $0.01
    14 Mar 2024 $0.01 $0.00 0.00% 198,290 $0.01 $0.01 $0.01
    13 Mar 2024 $0.01 $0.00 0.00% 345,061 $0.01 $0.01 $0.01
    12 Mar 2024 $0.01 $0.00 0.00% 181,359 $0.01 $0.01 $0.01
    11 Mar 2024 $0.01 $0.00 0.00% 671,684 $0.01 $0.01 $0.01
    08 Mar 2024 $0.01 $0.00 0.00% 2,327,051 $0.01 $0.01 $0.01
    07 Mar 2024 $0.01 $0.00 0.00% 1,321,270 $0.01 $0.01 $0.01
    06 Mar 2024 $0.01 $0.00 0.00% 16,181 $0.01 $0.01 $0.01
    05 Mar 2024 $0.01 $0.00 0.00% 269,152 $0.01 $0.01 $0.01
    04 Mar 2024 $0.01 $0.00 0.00% 25,000 $0.01 $0.01 $0.01
    01 Mar 2024 $0.01 $0.00 0.00% 340,168 $0.01 $0.01 $0.01
    29 Feb 2024 $0.01 $0.00 0.00% 294,865 $0.01 $0.01 $0.01
    28 Feb 2024 $0.01 $0.00 0.00% 1,504,657 $0.01 $0.01 $0.01
    27 Feb 2024 $0.01 $0.00 0.00% 6,058,632 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    06 Feb 2024 Ron Dufficy Expiry 548,077 $5,480
    As advised by the company. Lapsing of Performance Share rights,31,71,994 Rights
    23 Nov 2023 Ron Dufficy Exercise 902,778 $12,638
    Conversion of securities. 37,20,071 Rights
    23 Nov 2023 Ron Dufficy Issued 902,778 $12,638
    Conversion of securities.
    23 Nov 2023 Ron Dufficy Buy 902,778 $12,638
    Issue of options.
    23 Nov 2023 David (Dave) Fenlon Exercise 625,000 $8,750
    Conversion of securities. 17,15,753 Rights
    23 Nov 2023 David (Dave) Fenlon Issued 625,000 $8,750
    Conversion of securities.
    23 Nov 2023 David (Dave) Fenlon Issued 625,000 $8,750
    Issue of options.
    21 Sep 2023 Pauline Gately Sell 1,796,428 $10,778
    On-market trade.
    12 Sep 2023 Pauline Gately Sell 43,859 $350
    On-market trade.
    11 Sep 2023 Pauline Gately Sell 803,976 $6,431
    On-market trade.
    08 Sep 2023 Pauline Gately Sell 705,318 $5,642
    On-market trade.
    31 Aug 2023 Ron Dufficy Exercise 902,778 $9,027
    Conversion of securities. 5,922,849 Rights
    31 Aug 2023 Ron Dufficy Issued 902,778 $9,027
    Issue of options.
    31 Aug 2023 Ron Dufficy Issued 902,778 $9,027
    Conversion of securities.
    31 Aug 2023 David (Dave) Fenlon Issued 625,000 $6,250
    Issue of options.
    31 Aug 2023 David (Dave) Fenlon Issued 625,000 $6,250
    Conversion of securities.
    31 Aug 2023 David (Dave) Fenlon Exercise 625,000 $6,250
    Conversion of securities. 23,40,753 Rights
    31 Aug 2023 Helen Wiseman Issued 763,889 $7,638
    Conversion of securities.
    31 Aug 2023 Helen Wiseman Issued 763,889 $7,638
    Issue of options.
    31 Aug 2023 Helen Wiseman Exercise 763,889 $7,638
    Conversion of securities. 33,35,091 Rights
    07 Jun 2023 Ron Dufficy Issued 555,556 $7,777
    Participation in share purchase plan.
    07 Jun 2023 Helen Wiseman Issued 555,556 $7,777
    Participation in share purchase plan.
    31 May 2023 Ron Dufficy Exercise 3,478,785 $52,181
    Conversion of securities. 68,25,627 Rights
    31 May 2023 Ron Dufficy Issued 4,778,785 $105,554
    Issue of securities. 1,03,04,412 Rights
    31 May 2023 Ron Dufficy Issued 3,611,112 $65,000
    Employee Share Ownership Plan/Directors Salary Sacrifice. 55,25,627 Rights
    31 May 2023 Ron Dufficy Buy 3,478,785 $52,181
    Conversion of securities.
    31 May 2023 David (Dave) Fenlon Issued 2,500,000 $45,000
    Director remuneration. 29,65,753 Rights
    31 May 2023 Helen Wiseman Issued 3,055,556 $55,000
    Director remuneration. 40,98,980 Rights
    26 May 2023 Helen Wiseman Issued 555,556 $10,000
    Participation in share purchase plan.
    26 May 2023 Helen Wiseman Issued 555,556 $10,000
    Participation in share purchase plan.
    26 May 2023 Ron Dufficy Issued 555,556 $10,000
    Participation in share purchase plan.
    06 Apr 2023 Paul Benhaim Expiry 652,566 $14,356
    As advised by the company. lapse of performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David (Dave) Fenlon Non-Executive DirectorNon-Executive Chairman Mar 2022
    Mr Fenlon has over 30 years of experience in the FMCG and consumer sectors. He is currently CEO of The Platform Alliance Group, Non-Executive Chair for Nutritional Growth Solutions (ASX: NGS) and Non-Executive Director of Quest for Life Foundation. He was previously Group CEO and MD of BWX Limited (ASX: BWX), and prior to that, was MD for Australia and New Zealand at Blackmores (ASX: BKL). David has worked with retail brands both in Australia and offshore, with a strong focus on strategic planning and business transformation. David's experience also includes holding positions in Tesco throughout Europe and Safeway in the UK and he was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. He is member of Risk Committee.
    Mr Ron Dufficy Chief Executive OfficerManaging Director Apr 2023
    Mr Dufficy is a senior finance executive having held various financial leadership roles with ASX-listed companies such as CSR Ltd and Aristocrat Leisure Ltd. Ron has experience in regulated markets including being based in the USA for 9 years, most recently as Chief Financial Officer for Aristocrat's largest and most profitable division, responsible for developing and implementing strategies to improve profit margins, grow market share and creating a global shared services organisation.
    Ms Pauline Therese Gately Non-Executive Director Aug 2023
    --
    Ms Sarah Prince Joint Company Secretary Apr 2023
    -
    Ms Josephine Lorenz Chief Financial OfficerJoint Company Secretary May 2023
    -
    Josephine Lorenz Chief Financial OfficerJoint Company Secretary
    -
    Ron Dufficy Global Chief Executive Officer
    -
    Josephine Lorenz Global Chief Financial Officer
    -
    Sarah Prince Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Raw With Life Pty Ltd (Benhaim Trading A/C) 29,209,217 9.24%
    Citicorp Nominees Pty Limited 16,300,377 5.15%
    D & G Health Llc 5,119,229 1.62%
    BNP Paribas Noms Pty Ltd (Drp) 4,411,662 1.39%
    BNP Paribas Nominees Pty Ltd Acf Clearstream 4,294,462 1.36%
    Mrs Kelly Danielle Vagg 3,537,770 1.12%
    Mr Eric Chi Keung Wong 2,310,226 0.73%
    Mr Michael Ernest Granata (The Granata Family A/C) 2,200,000 0.70%
    Merrill Lynch (Australia) Nominees Pty Limited 2,017,205 0.64%
    Mr Jia Hong Zhang 1,858,472 0.59%
    Panther Trading Pty Ltd (Panther A/C) 1,576,471 0.50%
    Mr Jyotindra Subedi 1,500,283 0.47%
    Mr Gabriel Georges Alkan 1,467,982 0.46%
    HSBC Custody Nominees (Australia) Limited 1,371,933 0.43%
    Ms Xiao Lan Wang 1,339,568 0.42%
    Eighteen Holdings Pty Ltd 1,300,000 0.41%
    Mr Raymond Windward Dyne 1,300,000 0.41%
    Mr Kieran John O'Brien 1,271,500 0.40%
    Kaneden Enterprises Pty Ltd (Roseburgh Family Super A/C) 1,200,000 0.38%
    Ms Siu Ling Wu & Mr Chung Yin Liu 1,194,135 0.38%

    Profile

    since

    Note